Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies
Authors
Keywords
-
Journal
CNS Neuroscience & Therapeutics
Volume 22, Issue 3, Pages 159-166
Publisher
Wiley
Online
2016-01-18
DOI
10.1111/cns.12484
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
- (2016) Malaz Malaz Boustani et al. Clinical Interventions in Aging
- Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies
- (2015) Yuta Manabe et al. Psychogeriatrics
- Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial
- (2015) Manabu Ikeda et al. Alzheimers Research & Therapy
- Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies
- (2015) Yuta Manabe et al. Psychogeriatrics
- Long-term efficacy of donepezil for relapse of visual hallucinations in patients with dementia with Lewy bodies
- (2014) Katsuyuki Ukai et al. Psychogeriatrics
- High-Dose Donepezil (23 mg/day) for the Treatment of Moderate and Severe Alzheimer's Disease: Drug Profile and Clinical Guidelines
- (2013) Jeffrey L. Cummings et al. CNS Neuroscience & Therapeutics
- Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study
- (2013) Manabu Ikeda et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled trial
- (2012) Etsuro Mori et al. ANNALS OF NEUROLOGY
- Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation
- (2012) Susanne Hartz et al. BMC Neurology
- Safety and Effectiveness of Donepezil on Behavioral Symptoms in Patients With Alzheimer Disease
- (2011) Manuel Martin Carrasco et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD
- (2011) Cheryl L.P. Vigen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment
- (2010) Manuel Fernández et al. BMC Neurology
- Neurochemical basis for symptomatic treatment of Alzheimer's disease
- (2010) Paul T. Francis et al. NEUROPHARMACOLOGY
- Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials
- (2009) Bengt Winblad et al. CURRENT MEDICAL RESEARCH AND OPINION
- Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial
- (2008) David L. Sultzer et al. AMERICAN JOURNAL OF PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started